Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy

被引：0
|
作者：
R. H. Enting
P. Portegies
机构：
[1] Department of Neurology,
[2] Academic Medical Center H2-214,undefined
[3] Meibergdreef 9,undefined
[4] 1105 AZ,undefined
[5] Amsterdam,undefined
[6] The Netherlands e-mail: P.Portegies@amc.uva.nl Tel.: +31-20-5663842 Fax: +31-20-6971438,undefined
来源：
Journal of Neurology | 2000年 / 247卷
关键词：
Key words Progressive multifocal leukoencephalopathy; Anti-HIV agents; Cytarabine; HIV infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We assessed survival in AIDS-related progressive multifocal leukoencephalopathy (PML) and the effect of cytarabine and antiretroviral therapy in a retrospective analysis of a series of consecutive 35 patients with AIDS-related PML in an academic AIDS referral center over ¶15 years. Treatment regimens consisted of highly active antiretroviral treatment (HAART), intravenous cytarabine, or both. Median survival after diagnosis in the overall series was 88 days. Patients with low CD4 cell count tended to have shorter survival. Seven patients (20%) had prolonged survival (> 1 year). Cytarabine did not affect survival. Seven patients were treated with HAART, which did not significantly improve survival. We conclude that the prognosis of AIDS-related PML is still poor, with a median survival of ¶3 months.
引用
收藏
页码：134 / 138
页数：4
相关论文
共 50 条
  • [1] Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy
    Enting, RH
    Portegies, P
    JOURNAL OF NEUROLOGY, 2000, 247 (02) : 134 - 138
  • [2] Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy
    Cinque, P
    Casari, S
    Bertelli, D
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (12): : 848 - 849
  • [3] Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy - reply
    Hall, CD
    Yiannoutsos, C
    Clifford, DB
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (12): : 849 - 849
  • [4] Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy
    Mayo, J
    Collazos, J
    Martínez, E
    AIDS, 1998, 12 (13) : 1720 - 1722
  • [5] Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection
    Inui, K
    Miyagawa, H
    Sashihara, J
    Miyoshi, H
    Tanaka-Taya, K
    Nishigaki, T
    Teraoka, S
    Mano, T
    Ono, J
    Okada, S
    BRAIN & DEVELOPMENT, 1999, 21 (06): : 416 - 419
  • [6] Progressive multifocal leukoencephalopathy unmasked by antiretroviral therapy for HIV
    Coomes, Eric A.
    Heendeniya, Amila
    Bunce, Paul E.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (42) : E1260 - E1260
  • [7] Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy
    Tantisiriwat, W
    Tebas, P
    Clifford, DB
    Powderly, WG
    Fichtenbaum, CJ
    CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) : 1152 - 1154
  • [8] Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy
    Miralles, P
    Berenguer, J
    Lacruz, C
    Cosín, J
    López, JC
    Padilla, B
    Muñoz, L
    Garcia-de-Viedma, D
    AIDS, 2001, 15 (14) : 1900 - 1902
  • [9] The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy
    Cinque P.
    Pierotti C.
    Viganò M.G.
    Bestetti A.
    Fausti C.
    Bertelli D.
    Lazzarin A.
    Journal of NeuroVirology, 2001, 7 (4) : 358 - 363
  • [10] The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy
    Cinque, P
    Pierotti, C
    Viganò, MG
    Bestetti, A
    Fausti, C
    Bertelli, D
    Lazzarin, A
    JOURNAL OF NEUROVIROLOGY, 2001, 7 (04) : 358 - 363
12345